Dyslipidemia highly relates to the risk of CAD, which related to increased serum levels of total cholesterol (TC) [4], triglyceride (TG) [5], low-density lipoprotein cholesterol (LDL-C) [6], and apolipoprotein (Apo) B [7], combined with decreased levels of high-density lipoprotein cholesterol (HDL-C) [8], ApoA1 and the ApoA1/ApoB ratio [8]. This evidence concerns the gene APOB and metabolic syndrome.